Aastrom Biosciences, Inc. (ASTM) Announces One-for-Eight Reverse Stock Split
2/9/2010
More...
|
Bohai Pharmaceuticals Group, Inc. Announces Ticker Symbol Change to "BOPH" Effective Today
2/9/2010
More...
|
Chattem, Inc. (CHTT) Gives Notice of Fundamental Change Conversion Rights to Holders of Convertible Senior Notes
2/9/2010
More...
|
Nabi Biopharmaceuticals (NABI) Announces Mailing of Definitive Proxy Statement
2/9/2010
More...
|
EpiCept Corporation (EPCT) Establishes At-the-Market Public Stock Offering Program
2/8/2010
More...
|
Inhibitex, Inc. (INHX) Regains Compliance with NASDAQ Listing Requirements
2/8/2010
More...
|
Vyteris, Inc. Announces Private Placement of $1.06 Million of Senior Subordinated Convertible Notes
2/8/2010
More...
|
Nuvo Research Inc. (NRI.TO) Announces Early Redemption of 5% Convertible Debentures
2/5/2010
More...
|
BioMarin Pharmaceutical Inc. (BMRN) Announces 2010 Guidance
2/5/2010
More...
|
EntreMed, Inc. (ENMD) Raises Additional $2.5 Million In Registered Direct Offering
2/5/2010
More...
|
ALDA Pharmaceuticals Corporation (APH.V) Named as Part of 2010 TSX Venture 50
2/5/2010
More...
|
Bio-Rad Laboratories, Inc. (BIO) Announces Completion of Exchange Offer
2/5/2010
More...
|
Mirrx Therapeutics A/S Secures Seed Financing For Development Of Novel Microrna- Blocking Technology
2/4/2010
More...
|
Novo Nordisk A/S (NVO) Director/PDMR Shareholding
2/4/2010
More...
|
Sinovac Beijing Announces Closing of Common Share Offering
2/3/2010
More...
|
Achillion Pharmaceuticals, Inc. Announces Closing of Underwriters' Over-Allotment Option
2/3/2010
More...
|
ULURU Inc. to Raise $1.0 Million in Registered Direct 'At The Market' Offering
2/3/2010
More...
|
Stryker to Host Analyst Meeting
2/3/2010
More...
|
ImmunoGen, Inc. (IMGN) Announces Webcast of its Investment Community Meeting on February 25, 2010
2/3/2010
More...
|
EpiCept Corporation (EPCT) Regains Nasdaq Compliance
2/3/2010
More...
|
Medical Marijuana, Inc. Appoints New President and Reduces Capitalization Structure
2/3/2010
More...
|
Novo Nordisk A/S (NVO): Director/PDMR Shareholding
2/3/2010
More...
|
Healthnostics (HNST) Provides Shareholder Update
2/3/2010
More...
|
XOMA (US) LLC (XOMA) Announces $21 Million Underwritten Offering of Common Shares and Warrants
2/2/2010
More...
|
Theravance, Inc. (THRX) Announces New Employment Inducement Awards
2/2/2010
More...
|
Cannasat Therapeutics Inc. (CTH.TO) Update (February 1, 2010) (Letter from CEO)
2/2/2010
More...
|
Merck & Co., Inc. (MRK): Potential Remains For HIV Drug Despite Trial Disappointment
2/2/2010
More...
|
Thermo Fisher Scientific (TMO) Provides Notice of Contingent Interest Payment to Debenture Holders
2/1/2010
More...
|
Sinovac Biotech Ltd. (SNVBF) Announces Exercise of Over-Allotment Option
2/1/2010
More...
|
Proximagen Neuroscience plc (PRX.L) Strategic Update
2/1/2010
More...
|
NexMed (NEXM) Granted Request for Continued Listing on NASDAQ
2/1/2010
More...
|
Bederra Corporation Reports Current Share Structure
1/29/2010
More...
|
Bederra Corporation Announces Board Meeting Regarding Stock Buyback
1/29/2010
More...
|
Bio-Rad Laboratories, Inc. (BIO) Announces Extension of Exchange Offer
1/29/2010
More...
|
Bio-Rad Laboratories, Inc. (BIO) Announces Extension of Exchange Offer
1/29/2010
More...
|
Ambrilia Biopharma Inc. Obtains a Third Extension of CCAA Stay Order
1/29/2010
More...
|
Immunovaccine Inc. Grants Stock Options
1/29/2010
More...
|
PDL BioPharma, Inc. (PDLI) Announces Two $0.50 Dividends in 2010 Distribution Dates of April 1 and October 1, 2010
1/29/2010
More...
|
Gilead Sciences, Inc. (GILD) Announces Share Repurchase Program
1/29/2010
More...
|
Incyte Corporation (INCY) Announces Redemption of Its 3½% Convertible Senior Notes Due 2011 and Its 3½% Convertible Subordinated Notes Due 2011
1/29/2010
More...
|
Flexion Therapeutics Announces Agreements with Four Major Pharmaceutical Companies Such As AstraZeneca PLC (AZN) (JOBS) And Merck Serono (JOBS); Closes Series A Financing Round At $42 Million
1/29/2010
More...
|
Perrigo Company (PRGO) Announces Quarterly Dividend
1/28/2010
More...
|
Neovasc Inc. (NVC) Completes First Tranche of $1.329 Million Non-brokered Private Placement
1/28/2010
More...
|
Pharmasset, Inc. (VRUS) Announces Proposed Public Offering of Common Stock
1/28/2010
More...
|
Pharmasset, Inc. (VRUS) Prices Underwritten Offering of Common Stock
1/28/2010
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Receives Notice of Intention to Nominate Directors at 2010 Meeting of Shareholders
1/28/2010
More...
|
Sinovac Biotech Ltd. (SNVBF) Announces Upsizing and Pricing of Common Share Offering
1/28/2010
More...
|
GTC Biotherapeutics (GTCB) Provides Recombinant FVIIa Regulatory Update
1/28/2010
More...
|
Chattem, Inc. (CHTT) Gives Notice of Anticipated Fundamental Change Conversion Rights to Holders of Convertible Senior Notes and Elects to Settle All Conversions Occurring in Connection with Fundamental Change 100% in Cash
1/28/2010
More...
|
International Stem Cell Corporation Announces Shareholder Conference Call
1/28/2010
More...
|
Chemaphor Inc. (CFR.TO) Project Chosen to Receive Share of Government of Canada Investment in R&D to Drive Growth in Atlantic Canada
1/28/2010
More...
|
Japan Drug Firm Otsuka Pharmaceutical Co., Ltd. (JOBS) to Go Public, Say Sources
1/28/2010
More...
|
ReNeuron: Regulatory Update
1/28/2010
More...
|
Virginia Gov. McDonnell Proposes More Biotech Funding
1/27/2010
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Regains NASDAQ Compliance
1/27/2010
More...
|
Medicure Inc. (MCU) Announces TSX Delisting and Intention to Apply for Alternative Listing
1/27/2010
More...
|
BioCurex Inc. (BOCX) Announces Closing of Public Offering
1/26/2010
More...
|
Eribis Pharmaceuticals Receives Investment for Clinical Development of Novel Cardiovascular Therapy
1/26/2010
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Completes Previously Announced Registered Direct Offering
1/26/2010
More...
|
La Jolla Pharmaceutical Company (LJPC) Receives Nasdaq Delisting Notice and Intends to Appeal Determination
1/26/2010
More...
|
PerkinElmer, Inc. (PKI) Board Declares Quarterly Dividend
1/26/2010
More...
|
Radient Pharmaceuticals Submits Business Plan for Continued NYSE Amex Listing
1/26/2010
More...
|
Celtic Pharma And PolyTherics Announce Investment Into Novel Biopharmaceutical Programme
1/26/2010
More...
|
ChinaBio Today: Hong Kong Led Global Exchanges in 2009 IPOs
1/26/2010
More...
|
AEterna Zentaris (AEZS) Receives The Nasdaq Stock Market -- New York Notification Related to Minimum Bid Price
1/25/2010
More...
|
Vion Pharmaceuticals (VION) Issues Management Statement Regarding Trading Volume of Company's Common Stock
1/25/2010
More...
|
Mentor Corporation (MNTR) Capital Chairman Highlights $0.91/Share Non-GAAP Gains from Cancer Portfolio Appreciation
1/25/2010
More...
|
Kane Biotech Inc. (KNE) Announces Grant of Options
1/25/2010
More...
|
Ambrilia Biopharma Inc. Provides Bi-Weekly Status Update
1/25/2010
More...
|
Shandong Luoxin Pharma Lists ADSs on OTCQX Exchange
1/25/2010
More...
|
Achillion Pharmaceuticals, Inc. Prices $21.4 Million Public Offering of Common Stock
1/22/2010
More...
|
Aastrom Biosciences, Inc. (ASTM) Announces Closing of Unit Offering
1/22/2010
More...
|
Achillion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
1/22/2010
More...
|
PDL BioPharma, Inc. (PDLI) Provides Federal Income Tax Information Regarding 2009 Dividend Payments
1/22/2010
More...
|
Centene Corporation Announces Pricing of Follow-On Public Offering
1/22/2010
More...
|
Access Pharmaceuticals (ACCP) Raises $6.3 Million In Registered Direct Offering
1/22/2010
More...
|
Covidien (COV) Declares Quarterly Cash Dividend
1/22/2010
More...
|
Curis, Inc. (CRIS) Announces $16.25 Million Registered Direct Offering
1/22/2010
More...
|
Pall Corporation (PLL) Increases Quarterly Dividend
1/22/2010
More...
|
Columbia Laboratories, Inc. (CBRX) to Host Analyst and Investor Day on January 28, 2010
1/22/2010
More...
|
IntelGenx Corp. Grants Options to IR Firm
1/22/2010
More...
|
Roche: Novel Herceptin Formulation Promises Greater Convenience
1/22/2010
More...
|
Mylan Inc. (MYL) Declares Quarterly Preferred Stock Dividend
1/21/2010
More...
|
EntreMed, Inc. (ENMD) Receives The Nasdaq Stock Market -- New York Staff Determination Letter Regarding Noncompliance with Minimum Bid Price Rule and Requests Hearing
1/21/2010
More...
|
AMAG Pharmaceuticals, Inc. (AMAG) Announces Pricing of Public Offering of 3,600,000 Shares of Common Stock
1/21/2010
More...
|
InterMune, Inc. (ITMN) Announces Pricing of $98.7 Million Public Offering of Common Stock
1/21/2010
More...
|
PhotoMedex, Inc. (PHMD) Regains Nasdaq Compliance
1/21/2010
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) to Raise Up to $7.9 Million in Registered Direct Offering
1/21/2010
More...
|
InterMune, Inc. (ITMN) Announces Proposed Public Offering of Common Stock
1/20/2010
More...
|
ProChon Biotech Ltd. Closes $3.95 Million Bridge Loan
1/20/2010
More...
|
PuriCore Pre-Close Trading Update for Year Ending December 31, 2009
1/20/2010
More...
|
Simulations Plus (SLP) Announces Renewed Share Repurchase Program
1/20/2010
More...
|
Targeted Genetics Corporation (TGEN) Receives Delisting Determination
1/20/2010
More...
|
AMAG Pharmaceuticals, Inc. (AMAG) Announces Proposed Offering of 3,000,000 Shares of Common Stock
1/20/2010
More...
|
ArthroCare Corporation (ARTC) Shares to Begin Trading on NASDAQ Global Market
1/20/2010
More...
|
China Pediatric Pharmaceuticals, Inc. (LHSI) Files Application for NASDAQ Listing
1/20/2010
More...
|
Med BioGene Announces Date of Annual and Special Meeting and Adoption of Shareholder Rights Plan
1/20/2010
More...
|
BioExx Specialty Proteins Ltd. Receives Final Approval to Commence Trading on TSX
1/20/2010
More...
|
GeckoSystems International Corporation (GCKO.PK)' Common Stock Quoted on Pink Sheets Current Information Tier
1/20/2010
More...
|
McKesson Corporation Declares Quarterly Dividend January 20, 2010
1/20/2010
More...
|
US and EU Regulators Close in on Pharmaceutical Pay-for-delay Deals
1/19/2010
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Announces Distribution of Supplemental Information In Connection with Special Meeting of Shareholders
1/19/2010
More...
|
Accelr8 Technology Corporation (OTC-BB: ACLY) Begins Private Equity Sale and Presents Updates
1/19/2010
More...
|
Titan Pharmaceuticals (TTP) Files Form 10 for Re-registration of the Company With the Securities and Exchange Commission
1/19/2010
More...
|
Centene Corporation Announces Follow-on Public Offering
1/19/2010
More...
|
NYSE Amex Accepts Senesco Technologies, Inc. (SNT)'s Plan of Compliance
1/19/2010
More...
|
Endo Pharmaceuticals (ENDP) Announces Receipt of Paragraph IV Certification
1/19/2010
More...
|
The Female Health Company Initiates Cash Dividend Policy Company Reiterates FY2010 Unit Sales and Earnings Guidance
1/19/2010
More...
|
Synta Pharmaceuticals Sells Additional $3.75 Million of Common Stocks
1/19/2010
More...
|
Letter to the Shareholders of ALDA Pharmaceuticals Corporation (APH.V)
1/19/2010
More...
|
Biotech IPOs On The Rise In Mass.
1/15/2010
More...
|
Aastrom Biosciences, Inc. (ASTM) Announces Pricing of Unit Offering
1/15/2010
More...
|
Athersys, Inc. Files Shelf Registration Statement
1/15/2010
More...
|
DexCom Announces the Sale of 3.5 Million Shares of Common Stock
1/15/2010
More...
|
EpiCept Corporation (EPCT) Announces Reverse Split of Common Stock
1/15/2010
More...
|
Geron Corporation (GERN) Announces Warrant Exchange
1/15/2010
More...
|
Becton, Dickinson and Company (BDX) Announces Webcast of Annual Meeting of Shareholders
1/15/2010
More...
|
Cortex Pharmaceuticals, Inc. (COR) Announces $1.5 Million Private Placement
1/15/2010
More...
|
Merz Pharma Group Commences Tender Offer for All Outstanding Shares of BioForm Medical, Inc.
1/15/2010
More...
|
Repros Therapeutics Inc. (RPRX) Approved for Trading on Nasdaq Capital Market
1/15/2010
More...
|
Bioanalytical Systems, Inc. (BASI) Reports Financial Results for Fiscal 2009
1/15/2010
More...
|
Cell Therapeutics, Inc. (CTIC) Announces Institutional Investors Purchase $30 Million of Preferred Stock and Warrants
1/14/2010
More...
|
The Nasdaq Stock Market -- New York Trading for Oxygen Biotherapeutics, Inc. (OXBO) Shares to Begin January 15, 2010
1/14/2010
More...
|
BioInvent Announces a Directed New Share Issue of SEK 150 Million
1/14/2010
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Completes Previously Announced Registered Direct Offering
1/14/2010
More...
|
Columbia Laboratories, Inc. (CBRX) Regains Compliance with NASDAQ Listing Standards
1/14/2010
More...
|
Forbes Medi-Tech Inc. (FMTI) Appeals NASDAQ Listing Suspension
1/14/2010
More...
|
Moody's Upgrades Teva Pharmaceutical Industries Limited (TEVA) Rating to A3
1/14/2010
More...
|
Luna Innovations Inc. Complies with All NASDAQ Listing Criteria
1/14/2010
More...
|
Targeted Genetics Corporation (TGEN) Announces Decision to Delist and Deregister Its Common Stock
1/13/2010
More...
|
Medicure Inc. (MCU) Announces Process to Maximize Shareholder Value
1/13/2010
More...
|
Watson Pharmaceuticals, Inc. (WPI) to Host 'Investor Day 2010' on Thursday, January 21st in New York City
1/13/2010
More...
|
BioTie Therapies Corp. Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act relating to Decrease in Holdings
1/13/2010
More...
|
Targeted Genetics Corporation (TGEN) Exits NASDAQ to Conserve Cash
1/13/2010
More...
|
Beximco Pharmaceuticals: Completion of Preference Share Placing and Update on Strategy
1/12/2010
More...
|
YM BioSciences (YM.TO) Announces Result of Cytopia Limited (CYT.AX) Shareholder Vote
1/12/2010
More...
|
Biogen Idec, Inc. (California) (BIIB) to Provide Business Update at Investor Meeting
1/12/2010
More...
|
Trimeris, Inc. (TRMS) Receives Delisting Notice From NASDAQ
1/12/2010
More...
|
ZymoGenetics, Inc. (ZGEN) Announces Full Exercise of Overallotment Option by Underwriters
1/12/2010
More...
|
EntreMed, Inc. (ENMD) Completes Registered Direct Offering of $2.5 Million in Common Stock
1/12/2010
More...
|
'Big Pharma' Feed Biotech Startups Record Funds
1/11/2010
More...
|
A.P. Pharma, Inc. (APPA) Regains Compliance with Nasdaq Minimum Bid Price Rule
1/11/2010
More...
|
Alnylam Pharmaceuticals (ALNY) Provides Key Goals and Guidance for Next 12 to 18 Months
1/11/2010
More...
|
Vical Incorporated (VICL) Secures $25 Million Issuer Managed Equity Facility With Azimuth Opportunity, Ltd.
1/11/2010
More...
|
Repros Therapeutics Inc. (RPRX) Shelf Registrations of Stock Are Effective
1/11/2010
More...
|
SonoSite Inc. (SONO) Announces Planned Tender Offer to Repurchase $100 Million of Common Stock
1/11/2010
More...
|
Unilife Medical Solutions Results of Scheme Meetings and Extraordinary General Meeting
1/11/2010
More...
|
Tianyin Pharmaceutical Co, Inc. Announces Cash Dividend to Common Shareholders - Record Date January 29, 2010
1/11/2010
More...
|
Ambrilia Biopharma Inc. Provides Bi-Weekly Status Update
1/11/2010
More...
|
Oramed Pharmaceuticals Inc. (ORMP.OB) Announces Filing of Two Registration Statements
1/11/2010
More...
|
Synta Pharmaceuticals Nabs $25 Million in Stock Deal
1/8/2010
More...
|
Acetylon Pharmaceuticals Tops Up Series A Financing with $2 Million Note And Appoints Simon Jones VP Biology and Preclinical Development and John van Duzer VP Chemistry and Manufacturing
1/8/2010
More...
|
GTC Biotherapeutics (GTCB) Announces Conversion of LFB S.A.'s Preferred Stock into Common Shares and Provides a Portfolio Update
1/8/2010
More...
|
Thermo Fisher Scientific (TMO) Provides Notice of Conversion Right to Debenture Holders
1/8/2010
More...
|
Synta Pharmaceuticals Announces Proposed Public Offering of Common Stock
1/8/2010
More...
|
ChromoCure, Inc. Releases Investor Guidance on Short-Term Business Objectives
1/8/2010
More...
|
Forbes Medi-Tech Inc. (FMTI) Provides Update on NASDAQ Listing
1/8/2010
More...
|
Labopharm (DDS.TO) Settles $1 Million Draw Down Under Standby Equity Distribution Agreement
1/8/2010
More...
|
CPEX Pharmaceuticals Reports on SEC Filing by Arcadia Capital Advisors
1/8/2010
More...
|
Mologen AG (MOLGF.PK): Successful Capital Increase Completed As Planned
1/8/2010
More...
|
Troubled Genzyme Corporation (GENZ) Gets Backing of Major Shareholder Icahn
1/8/2010
More...
|
ZymoGenetics, Inc. (ZGEN) Prices Public Offering of Common Stock
1/7/2010
More...
|
ZymoGenetics, Inc. (ZGEN) Gets $79 Million in Stock Sale
1/7/2010
More...
|
BioTime (BTIM.PK) Subsidiary OncoCyte Corporation Receives Second $2,000,000 Equity Tranche; BioTime Plans Additional $2,250,000 Investment
1/7/2010
More...
|
Provectus Pharmaceuticals Inc. Reports to Shareholders on 2009 Accomplishments and Clinical Development Plans
1/7/2010
More...
|
Mentor Capital's Cancer Immunotherapy Index Closes 2009 with 85% Annualized Gains
1/7/2010
More...
|
ALDA Pharmaceuticals Corporation (APH.V) AGM Held on December 11, 2009
1/7/2010
More...
|
Genzyme Corporation (GENZ) in Truce with Dissident Shareholder
1/7/2010
More...
|
CareFusion Corporation Announces Exchange Offer for 4.125% Senior Notes Due 2012, 5.125% Senior Notes Due 2014, and 6.375% Senior Notes Due 2019
1/7/2010
More...
|
GenVec Inc. (GNVC) Rallies on The Nasdaq Stock Market -- New York Compliance
1/7/2010
More...
|
Conversion Right Triggered for Laboratory Corporation of America Holdings (LabCorp) (LH)'s Zero Coupon Convertible Subordinated Notes Due 2021
1/6/2010
More...
|
MediciNova, Inc. Extends Conversion Deadline to January 11, 2010
1/5/2010
More...
|
NovaDel Pharma (NVD) Announces Agreement with Debt Holder to Convert Their Notes to Equity
1/5/2010
More...
|
Osteologix Inc. Announces Financing
1/5/2010
More...
|
Luna Innovations Inc. to Provide Corporate Update on January 11, 2010
1/5/2010
More...
|
deCODE genetics, Inc. (DCGN) Receives Trading Suspension and Delisting Notice From The Nasdaq Stock Market -- New York
1/5/2010
More...
|
Extendicare Inc. (EXE) REIT Announces Commencement of Renewed Normal Course Issuer Bid
1/5/2010
More...
|
ChinaBio Today: Mixed Results for China Life Science US IPOs
1/4/2010
More...
|
ChinaBio Today: China-listed Life Science IPOs Are Hot
1/4/2010
More...
|
ChinaBio Today The Week in Review: Year-End IPO Review
1/4/2010
More...
|
Investment Boosts SpheriTech's Phenomenal Growth
1/4/2010
More...
|
deCODE genetics, Inc. (DCGN) Receives The Nasdaq Stock Market -- New York Deficiency Notice
1/4/2010
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Announces Further Adjournment of Special Shareholder Meeting
1/4/2010
More...
|
China Cord Blood Corporation Announces Full Exercise of Over-Allotment Option
1/4/2010
More...
|
Emergent Health Corp. (EMGE) Announces Symbol Change Correction
1/4/2010
More...
|
Antigenics Inc. (New York) (AGEN) Receives NASDAQ Delisting Notification
1/4/2010
More...
|
Taro Pharmaceutical Industries Ltd. (TARO) Reports Voting Results from Its Annual General Meeting
1/4/2010
More...
|
Ventana Biotech Inc.: Sale of IP Update
1/4/2010
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Registers for Stock Sale of up to $50 Million
12/30/2009
More...
|
New Number of Shares and Votes In Karo Bio AB
12/30/2009
More...
|
Origin Agritech Limited (SEED) Announces Completion of the Second Notes Repurchase Agreement
12/30/2009
More...
|
Bio-Rad Laboratories, Inc. (BIO) Announces Commencement of Exchange Offer of Its 8.00% Senior Subordinated Notes Due 2016 for Registered Notes
12/30/2009
More...
|
VIA Pharmaceuticals, Inc. Receives Delisting Notification From The Nasdaq Stock Market -- New York
12/30/2009
More...
|
HEARx Canada Inc. (HUX) Announces Voluntary Delisting of Exchangeable Shares
12/30/2009
More...
|
Victhom Human Bionics (VHB) to List on TSX Venture Exchange and Voluntarly Delist From Toronto Stock Exchange
12/30/2009
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Invites Public to Listen to Analyst Meeting Webcast
12/29/2009
More...
|
Ambrilia Biopharma Inc. Provides Bi-Weekly Status Update
12/29/2009
More...
|
Vyteris, Inc. Announces Restructuring of Its Balance Sheet Through a $2.3 Million Non-Dilutive Capital Raise and Conversion of Approximately $20 Million of Debt and Preferred Shares Into Common Stock
12/29/2009
More...
|
Radient Pharmaceuticals Informed by AMEX of Possible Delisting
12/29/2009
More...
|
Inhibetex Therapeutics Inc. Receives NASDAQ Notification
12/28/2009
More...
|